HIV pozitif olgularda okült hepatit B varlǐmin araştirilmasi

Translated title of the contribution: Investigation of occult hepatitis B in HIV infected patients

Akif Altinbaş, Koray Ergünay, Nursel Çalik Başaran, Alpaslan Alp, Didem Turgut, Gülşen Hasçelik, Ömrüm Uzun, Serhat Ünal

Research output: Contribution to journalArticle

Abstract

Due to their shared transmission route, hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections can be observed in human immunodeficiency virus (HIV)-infected cases and are associated with more severe clinical courses. The detection of HBV DNA despite HBV surface antigen (HBsAg) seronegativity is defined as occult HBV infections. According to the current seroepidemiological data, Turkey is classified as an intermediate HBV, low HIV endemic region. Occult HBV infections have previously been reported from Turkey but has not been investigated previously in HIV infected cohorts. The aim of this study was to identify occult HBV infections in HIV-infected persons. Twenty-eight HIV-positive cases followed-up at Hacettepe University Hospital, Infectious Diseases Unit were included in the study after informed consent. For the detection of HBsAg, anti-HBs and anti-HCV, commercial ELISA tests (Architect System, Abbott Diagnostics, USA) were employed. Absolute CD4+ and CD8+ T-cell counts were determined via flow cytometry. HIV viral load was calculated via COBAS TaqMan HIV-1 Real-time PCR (Roche Diagnostics, USA) and the presence of HBV DNA was evaluated via COBAS TaqMan HBV Real-time PCR (Roche Diagnostics, USA), in addition to a nested PCR assay targeting HBV S gene. The mean age of the study group was 43.2 (range between 27-65) years, 64.3% (18/28) of them were males and the mean duration of HIV infection was 4.2 (2-11) years. Mean CD4+ ve CD8+ T-cell counts were 414 ± 267 cells/mm 3 and 854 ± 293 cells/mm 3, respectively. Twenty-six (92.8%) cases were under highly-active anti-retroviral therapy at the time of the study, 88.5% of which included HBVactive drugs (lamivudine or tenofovir). HIV RNA were found negative in 11 (39.3%) patients, of those nine (81.8%) were the cases who treated with HBV-active antiretroviral therapy. HBsAg were negative in all of the 28 patients, while the positivity rates of anti-HBs and anti-HCV were 39.3% (11/28) and 3.6% (1/28), respectively. All samples were negative for HBV DNA via the commercial real-time PCR and in-house nested PCR assays. The absence of occult HBV in the study group may indicate the absence of occult HBV or suppression of viral replication due to the anti-retroviral therapy. In conclusion, further large-scale studies are required to fully understand the impact of occult HBV in HIV-infected patients in Turkey.

Original languageTurkish
Pages (from-to)353-358
Number of pages6
JournalMikrobiyoloji Bulteni
Volume45
Issue number2
StatePublished - Apr 2011
Externally publishedYes

Fingerprint

Hepatitis B
Hepatitis B virus
HIV
Virus Diseases
Turkey
Hepacivirus
Real-Time Polymerase Chain Reaction
Tenofovir
Surface Antigens
DNA
Cell Count
T-Lymphocytes
Polymerase Chain Reaction
Lamivudine
Time and Motion Studies
Hepatitis B Surface Antigens
Viral Load
Informed Consent
Coinfection
Communicable Diseases

Keywords

  • HBV
  • HBV-DNA
  • Hepatitis B virus
  • HIV
  • Human immunodeficiency virus
  • Occult hepatitis
  • PCR

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Immunology and Microbiology(all)

Cite this

Altinbaş, A., Ergünay, K., Çalik Başaran, N., Alp, A., Turgut, D., Hasçelik, G., ... Ünal, S. (2011). HIV pozitif olgularda okült hepatit B varlǐmin araştirilmasi. Mikrobiyoloji Bulteni, 45(2), 353-358.

HIV pozitif olgularda okült hepatit B varlǐmin araştirilmasi. / Altinbaş, Akif; Ergünay, Koray; Çalik Başaran, Nursel; Alp, Alpaslan; Turgut, Didem; Hasçelik, Gülşen; Uzun, Ömrüm; Ünal, Serhat.

In: Mikrobiyoloji Bulteni, Vol. 45, No. 2, 04.2011, p. 353-358.

Research output: Contribution to journalArticle

Altinbaş, A, Ergünay, K, Çalik Başaran, N, Alp, A, Turgut, D, Hasçelik, G, Uzun, Ö & Ünal, S 2011, 'HIV pozitif olgularda okült hepatit B varlǐmin araştirilmasi', Mikrobiyoloji Bulteni, vol. 45, no. 2, pp. 353-358.
Altinbaş A, Ergünay K, Çalik Başaran N, Alp A, Turgut D, Hasçelik G et al. HIV pozitif olgularda okült hepatit B varlǐmin araştirilmasi. Mikrobiyoloji Bulteni. 2011 Apr;45(2):353-358.
Altinbaş, Akif ; Ergünay, Koray ; Çalik Başaran, Nursel ; Alp, Alpaslan ; Turgut, Didem ; Hasçelik, Gülşen ; Uzun, Ömrüm ; Ünal, Serhat. / HIV pozitif olgularda okült hepatit B varlǐmin araştirilmasi. In: Mikrobiyoloji Bulteni. 2011 ; Vol. 45, No. 2. pp. 353-358.
@article{36251e30cfcc48cbba59562d86aa9620,
title = "HIV pozitif olgularda ok{\"u}lt hepatit B varlǐmin araştirilmasi",
abstract = "Due to their shared transmission route, hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections can be observed in human immunodeficiency virus (HIV)-infected cases and are associated with more severe clinical courses. The detection of HBV DNA despite HBV surface antigen (HBsAg) seronegativity is defined as occult HBV infections. According to the current seroepidemiological data, Turkey is classified as an intermediate HBV, low HIV endemic region. Occult HBV infections have previously been reported from Turkey but has not been investigated previously in HIV infected cohorts. The aim of this study was to identify occult HBV infections in HIV-infected persons. Twenty-eight HIV-positive cases followed-up at Hacettepe University Hospital, Infectious Diseases Unit were included in the study after informed consent. For the detection of HBsAg, anti-HBs and anti-HCV, commercial ELISA tests (Architect System, Abbott Diagnostics, USA) were employed. Absolute CD4+ and CD8+ T-cell counts were determined via flow cytometry. HIV viral load was calculated via COBAS TaqMan HIV-1 Real-time PCR (Roche Diagnostics, USA) and the presence of HBV DNA was evaluated via COBAS TaqMan HBV Real-time PCR (Roche Diagnostics, USA), in addition to a nested PCR assay targeting HBV S gene. The mean age of the study group was 43.2 (range between 27-65) years, 64.3{\%} (18/28) of them were males and the mean duration of HIV infection was 4.2 (2-11) years. Mean CD4+ ve CD8+ T-cell counts were 414 ± 267 cells/mm 3 and 854 ± 293 cells/mm 3, respectively. Twenty-six (92.8{\%}) cases were under highly-active anti-retroviral therapy at the time of the study, 88.5{\%} of which included HBVactive drugs (lamivudine or tenofovir). HIV RNA were found negative in 11 (39.3{\%}) patients, of those nine (81.8{\%}) were the cases who treated with HBV-active antiretroviral therapy. HBsAg were negative in all of the 28 patients, while the positivity rates of anti-HBs and anti-HCV were 39.3{\%} (11/28) and 3.6{\%} (1/28), respectively. All samples were negative for HBV DNA via the commercial real-time PCR and in-house nested PCR assays. The absence of occult HBV in the study group may indicate the absence of occult HBV or suppression of viral replication due to the anti-retroviral therapy. In conclusion, further large-scale studies are required to fully understand the impact of occult HBV in HIV-infected patients in Turkey.",
keywords = "HBV, HBV-DNA, Hepatitis B virus, HIV, Human immunodeficiency virus, Occult hepatitis, PCR",
author = "Akif Altinbaş and Koray Erg{\"u}nay and {{\cC}alik Başaran}, Nursel and Alpaslan Alp and Didem Turgut and G{\"u}lşen Has{\cc}elik and {\"O}mr{\"u}m Uzun and Serhat {\"U}nal",
year = "2011",
month = "4",
language = "Turkish",
volume = "45",
pages = "353--358",
journal = "Mikrobiyoloji Bulteni",
issn = "0374-9096",
publisher = "Ankara Microbiology Society",
number = "2",

}

TY - JOUR

T1 - HIV pozitif olgularda okült hepatit B varlǐmin araştirilmasi

AU - Altinbaş, Akif

AU - Ergünay, Koray

AU - Çalik Başaran, Nursel

AU - Alp, Alpaslan

AU - Turgut, Didem

AU - Hasçelik, Gülşen

AU - Uzun, Ömrüm

AU - Ünal, Serhat

PY - 2011/4

Y1 - 2011/4

N2 - Due to their shared transmission route, hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections can be observed in human immunodeficiency virus (HIV)-infected cases and are associated with more severe clinical courses. The detection of HBV DNA despite HBV surface antigen (HBsAg) seronegativity is defined as occult HBV infections. According to the current seroepidemiological data, Turkey is classified as an intermediate HBV, low HIV endemic region. Occult HBV infections have previously been reported from Turkey but has not been investigated previously in HIV infected cohorts. The aim of this study was to identify occult HBV infections in HIV-infected persons. Twenty-eight HIV-positive cases followed-up at Hacettepe University Hospital, Infectious Diseases Unit were included in the study after informed consent. For the detection of HBsAg, anti-HBs and anti-HCV, commercial ELISA tests (Architect System, Abbott Diagnostics, USA) were employed. Absolute CD4+ and CD8+ T-cell counts were determined via flow cytometry. HIV viral load was calculated via COBAS TaqMan HIV-1 Real-time PCR (Roche Diagnostics, USA) and the presence of HBV DNA was evaluated via COBAS TaqMan HBV Real-time PCR (Roche Diagnostics, USA), in addition to a nested PCR assay targeting HBV S gene. The mean age of the study group was 43.2 (range between 27-65) years, 64.3% (18/28) of them were males and the mean duration of HIV infection was 4.2 (2-11) years. Mean CD4+ ve CD8+ T-cell counts were 414 ± 267 cells/mm 3 and 854 ± 293 cells/mm 3, respectively. Twenty-six (92.8%) cases were under highly-active anti-retroviral therapy at the time of the study, 88.5% of which included HBVactive drugs (lamivudine or tenofovir). HIV RNA were found negative in 11 (39.3%) patients, of those nine (81.8%) were the cases who treated with HBV-active antiretroviral therapy. HBsAg were negative in all of the 28 patients, while the positivity rates of anti-HBs and anti-HCV were 39.3% (11/28) and 3.6% (1/28), respectively. All samples were negative for HBV DNA via the commercial real-time PCR and in-house nested PCR assays. The absence of occult HBV in the study group may indicate the absence of occult HBV or suppression of viral replication due to the anti-retroviral therapy. In conclusion, further large-scale studies are required to fully understand the impact of occult HBV in HIV-infected patients in Turkey.

AB - Due to their shared transmission route, hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections can be observed in human immunodeficiency virus (HIV)-infected cases and are associated with more severe clinical courses. The detection of HBV DNA despite HBV surface antigen (HBsAg) seronegativity is defined as occult HBV infections. According to the current seroepidemiological data, Turkey is classified as an intermediate HBV, low HIV endemic region. Occult HBV infections have previously been reported from Turkey but has not been investigated previously in HIV infected cohorts. The aim of this study was to identify occult HBV infections in HIV-infected persons. Twenty-eight HIV-positive cases followed-up at Hacettepe University Hospital, Infectious Diseases Unit were included in the study after informed consent. For the detection of HBsAg, anti-HBs and anti-HCV, commercial ELISA tests (Architect System, Abbott Diagnostics, USA) were employed. Absolute CD4+ and CD8+ T-cell counts were determined via flow cytometry. HIV viral load was calculated via COBAS TaqMan HIV-1 Real-time PCR (Roche Diagnostics, USA) and the presence of HBV DNA was evaluated via COBAS TaqMan HBV Real-time PCR (Roche Diagnostics, USA), in addition to a nested PCR assay targeting HBV S gene. The mean age of the study group was 43.2 (range between 27-65) years, 64.3% (18/28) of them were males and the mean duration of HIV infection was 4.2 (2-11) years. Mean CD4+ ve CD8+ T-cell counts were 414 ± 267 cells/mm 3 and 854 ± 293 cells/mm 3, respectively. Twenty-six (92.8%) cases were under highly-active anti-retroviral therapy at the time of the study, 88.5% of which included HBVactive drugs (lamivudine or tenofovir). HIV RNA were found negative in 11 (39.3%) patients, of those nine (81.8%) were the cases who treated with HBV-active antiretroviral therapy. HBsAg were negative in all of the 28 patients, while the positivity rates of anti-HBs and anti-HCV were 39.3% (11/28) and 3.6% (1/28), respectively. All samples were negative for HBV DNA via the commercial real-time PCR and in-house nested PCR assays. The absence of occult HBV in the study group may indicate the absence of occult HBV or suppression of viral replication due to the anti-retroviral therapy. In conclusion, further large-scale studies are required to fully understand the impact of occult HBV in HIV-infected patients in Turkey.

KW - HBV

KW - HBV-DNA

KW - Hepatitis B virus

KW - HIV

KW - Human immunodeficiency virus

KW - Occult hepatitis

KW - PCR

UR - http://www.scopus.com/inward/record.url?scp=79958748560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958748560&partnerID=8YFLogxK

M3 - Article

C2 - 21644079

AN - SCOPUS:79958748560

VL - 45

SP - 353

EP - 358

JO - Mikrobiyoloji Bulteni

JF - Mikrobiyoloji Bulteni

SN - 0374-9096

IS - 2

ER -